Search company, investor...

Founded Year

1983

Stage

Reverse Merger | IPO

Total Raised

$3.5M

Market Cap

0.01B

Stock Price

1.67

About NTN Buzztime

NTN Buzztime is a company that focuses on the entertainment industry, specifically in the domain of social video games. The company's main offerings include bar trivia and social gaming software systems, designed to enhance customer engagement and retention in bar settings. It was founded in 1983 and is based in Carlsbad, California.

Headquarters Location

The Campus 5966 La Place Court Suite 100

Carlsbad, California, 92008,

United States

760-438-7400

Loading...

Loading...

NTN Buzztime Patents

NTN Buzztime has filed 2015 patents.

The 3 most popular patent topics include:

  • bearings (mechanical)
  • fluid dynamics
  • mechanical engineering
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/3/2020

2/13/2024

Industrial gases, Fluid dynamics, Casting (manufacturing), Fluid mechanics, Chemical processes

Grant

Application Date

2/3/2020

Grant Date

2/13/2024

Title

Related Topics

Industrial gases, Fluid dynamics, Casting (manufacturing), Fluid mechanics, Chemical processes

Status

Grant

Latest NTN Buzztime News

Brooklyn Immunotherapeutics Stock Price Increased Over 50% Pre-Market: Details You Should Know

Apr 6, 2021

The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) has increased by over 50% pre-market. This is what you should know about the company. The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) – a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer – has increased by over 50% pre-market. This is what you should know about the company. On March 26, the shares of Brooklyn ImmunoTherapeutics had commenced trading on the NYSE American under the symbol “BTX.” The day before that happened, Brooklyn ImmunoTherapeutics had completed a reverse merger with NTN Buzztime . Brooklyn Immunotherapeutics is focused on the advancement of IRX-2, which is a cytokine-based compound for the treatment of various cancers as well as opportunities in the area of gene editing/cell therapy through its option agreement with Factor Bioscience/Novellus. IRX-2 received both fast track designation and orphan drug designation from the FDA for this indication with topline results from the company’s Phase 2b clinical trial expected in the first half of next year. And IRX-2 is also being studied in clinical trials in multiple oncology indications, both as a single agent and in combination with other anti-cancer drugs including checkpoint inhibitors. After the closing of the reverse merger, the former members of Brooklyn ImmunoTherapeutics LLC collectively own approximately 96.25% of the outstanding common stock of Brooklyn and the stockholders of NTN Buzztime prior to the merger own the remaining 3.75% of Brooklyn’s outstanding common stock. And following the closing of the merger, there were approximately 41.5 million post-reverse split shares of common stock outstanding. There does not seem to be any news from the company that caused the stock price to surge pre-market. But a number of day traders on forums have cited the low float as a potential opportunity. There were a number of security ownership statements filed with the SEC showing how many shares the company executives beneficially owned, which is also being looked at as catalysts. Disclaimer: This article is intended for informational purposes. Prior to making any investment, you should conduct your own analysis and financial strategy.

NTN Buzztime Frequently Asked Questions (FAQ)

  • When was NTN Buzztime founded?

    NTN Buzztime was founded in 1983.

  • Where is NTN Buzztime's headquarters?

    NTN Buzztime's headquarters is located at The Campus 5966 La Place Court, Carlsbad.

  • What is NTN Buzztime's latest funding round?

    NTN Buzztime's latest funding round is Reverse Merger.

  • How much did NTN Buzztime raise?

    NTN Buzztime raised a total of $3.5M.

  • Who are the investors of NTN Buzztime?

    Investors of NTN Buzztime include Brooklyn ImmunoTherapeutics, Ault Global Holdings, Paycheck Protection Program and LRG Capital Group.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.